Cinv - Open Access .click

Results 171 to 180 of about 3,191 (210)

Some of the next articles are maybe not open access.

Palonosetron in allen CINV-Phasen effektiv

Info Onkologie, 2014
Palonosetron stellt als einziges Setron bei zytostatikainduzierter Ubelkeit und Erbrechen (CINV) in der akuten sowie der verzogerten Phase eine effektive Basisprophylaxe dar, wie aktuelle klinische Daten bestatigen.
openaire +1 more source

Current Management of CINV (Preprint)

BACKGROUND Chemotherapy-induced nausea and vomiting (CINV) significantly impact cancer patients undergoing treatment, affecting their quality of life and treatment adherence. Despite advances in antiemetic therapy, CINV remains a challenge, necessitating ongoing research and development of effective ...
openaire +1 more source

Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis

Supportive Care in Cancer, 2023
Lee Schwartzberg, , Eros Papademetriou
exaly

Dronabinol an alternative to ondansetron for CINV

Inpharma Weekly, 2005
openaire +2 more sources

<p>Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)</p>

Core Evidence, 2020
Francesco Giotta +2 more
exaly

Duration of CINV

2010
openaire +1 more source

Acute CINV

2010
openaire +1 more source

Oncologist perspectives on chemotherapy‐induced nausea and vomiting (CINV) management and outcomes: A quantitative market research‐based survey

Cancer Reports, 2018
Matti Aapro
exaly